"ÜberResearch provides critical information for funding organizations, and it is a natural partner for OnPAR," says Martin Dueñas, Director, Health Research Management Practice, Leidos Life Sciences.
ÜberResearch's Dimensions is a decision support system that analyzes strategic research investments by funders, universities, and other stakeholders throughout the research ecosystem. The platform provides insight into the international funding landscape, covering over
"We are thrilled to partner with
OnPAR with Dimensions will provide a global research knowledge management platform that will empower funding organizations and private industry to make more informed strategic investments. In addition, the data mining tools and analytics within OnPAR with Dimensions will facilitate greater perspective, and insight previously unavailable, by linking research projects and literature that were never before recognized as relevant, ultimately furthering advances in research discovery and development.
OnPAR is increasing its enrollment and will announce new members in spring 2017, including additional foundations, pharmaceutical companies, and other life sciences funding organizations across varied disease areas.
Any funding organization interested in becoming a member can find more information on the OnPAR website at https://onpar.leidosweb.com.
ÜberResearch, a member of the Digital Science family with Altmetric, Figshare, Readcube, and Symplectic, focuses on building Portfolio Analysis, Reviewer Identification, Categorization, and Search and Discovery systems for Research Funders. The ÜberResearch team has worked for over 15 years producing solutions that apply analytical technology like NLP to science content including publications, grants, patents, clinical trials, and more. Clients range from the largest funding agencies and most prestigious scientific publishers to the smallest foundations and non-profits. For more information, visit uberresearch.com.
Statements in this announcement, other than historical data and information, constitute forward-looking statements that involve risks and uncertainties. A number of factors could cause our actual results, performance, achievements, or industry results to be very different from the results, performance, or achievements expressed or implied by such forward-looking statements. Some of these factors include, but are not limited to, the risk factors set forth in the company's Annual Report on Form 10-K for the period ended